BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3434985)

  • 1. [New thrombolytic agents. Effect on the organization of care in myocardial infarction].
    Castaigne A; Duval-Moulin AM; Dubois Rande JL; Hervé C
    Ann Cardiol Angeiol (Paris); 1987 Dec; 36(10):577-81. PubMed ID: 3434985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Platelet activation in the early phases of acute myocardial infarction].
    Salvioni A; Giraldi F; Assanelli E; Lauri G; Grazi M; Pardea S; Marenzi G
    Cardiologia; 1998 Aug; 43(8):825-32. PubMed ID: 9808873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thrombolytic agents in myocardial infarction: results of large mortality studies].
    Slama MS; Motté G
    Rev Prat; 1992 Nov; 42(17):2143-9. PubMed ID: 1290036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombolytic therapy use for acute myocardial infarction and outcome in Qatar.
    Hadi HA; Al Suwaidi J; Bener A; Khinji A; Al Binali HA
    Int J Cardiol; 2005 Jul; 102(2):249-54. PubMed ID: 15982492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical applications of thrombolytic therapy.
    Mair FS
    Am Fam Physician; 1996 Nov; 54(6):2041-8. PubMed ID: 8900363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing the time to thrombolysis in acute myocardial infarction. Time to Thrombolysis Substudy of the National Registry of Myocardial Infarction-1.
    Lambrew CT; Bowlby LJ; Rogers WJ; Chandra NC; Weaver WD
    Arch Intern Med; 1997 Dec 8-22; 157(22):2577-82. PubMed ID: 9531226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pre-hospital thrombolysis].
    Castaigne A; Hervé C; Duval-Moulin AM; Dubois-Randé JL; Merlet P; Hittinger L
    Arch Mal Coeur Vaiss; 1990 Feb; 83 Spec No 1():41-5. PubMed ID: 2108646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decision support and the appropriate use of fibrinolysis in myocardial infarction.
    Kellett J
    Eff Clin Pract; 2001; 4(1):1-9. PubMed ID: 11234180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is transport with platelet GP IIb/IIIa inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? Randomised study. Early results.
    Dobrzycki S; Mezyński G; Kralisz P; Prokopczuk P; Nowak K; Kochman W; Zuk J; Bachórzewska-Gajewska H; Sawicki Z; Poniatowski B; Korecki J; Musiał WJ
    Kardiol Pol; 2006 Aug; 64(8):793-9; discussion 800-1. PubMed ID: 16981054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential cost effectiveness of tissue plasminogen activator among patients previously treated with streptokinase.
    Massel D
    Can J Cardiol; 1999 Feb; 15(2):173-9. PubMed ID: 10079776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Does streptokinase still have a role in the treatment of acute myocardial infarct?].
    Janousek S
    Vnitr Lek; 2003 Nov; 49(11):880-4. PubMed ID: 14689685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The safety and efficacy of systemic salvage thrombolysis in acute myocardial infarct].
    Sarullo FM; Schicchi R; Schirò M; Americo L; Bonnì G; Faraone N; Di Pasquale P; Castello A; Mauri F
    Ital Heart J Suppl; 2000 Jan; 1(1):81-7. PubMed ID: 10832123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thrombolytic therapy in acute myocardial infarct--is it being used to the fullest?].
    Carôla B; Calçada-Correia L; Pedro PG; Conduto R; Dionísio I; Fiuza M; Dias E; Vaz Carneiro A; Amador MG; de Pádua F; Lopes MG
    Rev Port Cardiol; 1996 Dec; 15(12):867-76, 863. PubMed ID: 9052962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Present-day thrombolytic therapy: therapeutic agents--pharmacokinetics and pharmacodynamics.
    Bell WR
    Rev Cardiovasc Med; 2002; 3 Suppl 2():S34-44. PubMed ID: 12556741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prehospital thrombolysis in acute myocardial infarction.
    Stern R; Arntz HR
    Eur J Emerg Med; 1998 Dec; 5(4):471-9. PubMed ID: 9919456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombolysis utilisation in acute myocardial infarction in Bahrain.
    Chawla AK; Nambiar CA; Murad AA
    Indian Heart J; 1996; 48(2):155-8. PubMed ID: 8682556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fibrinolytic treatment of acute myocardial infarction (author's transl)].
    Woitinas F; Begemann H
    Herz; 1981 Feb; 6(1):50-4. PubMed ID: 7216122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombolysis for acute myocardial infarction in Australasia 1999.
    Mountain D; Jelinek GA; O'Brien DL; Ingarfield SL; Jacobs IG; Lynch DM
    Emerg Med (Fremantle); 2002 Sep; 14(3):267-74. PubMed ID: 12487044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated infusion of streptokinase in acute myocardial infarction results in better TIMI flow grade in infarct-related artery.
    Dwivedi SK; Saran RK; Narain VS; Bansal S; Gupta R; Puri VK
    Indian Heart J; 2000; 52(1):40-4. PubMed ID: 10820932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early reperfusion and late clinical outcomes in patients presenting with acute myocardial infarction randomly assigned to primary percutaneous coronary intervention or streptokinase.
    Berrocal DH; Cohen MG; Spinetta AD; Ben MG; Rojas Matas CA; Gabay JM; Magni JM; Nogareda G; Oberti P; Von Schulz C; Doval H; Bazzino OO; Cagide A; Oliveri R; Grinfeld LR
    Am Heart J; 2003 Dec; 146(6):E22. PubMed ID: 14661011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.